#PharmEasy is reviving its #IPO plans after 2 years.
Board Meeting in Feb , 
Size &amp; Valuation will be discussed in the meeting.

There could also be some discussions on the company's reverse Merger with its listed Subsidiary Thyrocare Ltd

DM for shares✉️
#PharmEasy #IPO